Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

Published:2016-07-28 Issue:4 Volume:128 Page:504-507
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Short Nicholas J.¹^ORCID,Jabbour Elias²,Sasaki Koji²,Patel Keyur³,O’Brien Susan M.⁴,Cortes Jorge E.²,Garris Rebecca²,Issa Ghayas C.¹,Garcia-Manero Guillermo²,Luthra Rajyalakshmi³,Thomas Deborah²,Kantarjian Hagop²,Ravandi Farhad²

Affiliation:

1. Division of Cancer Medicine,

2. Department of Leukemia, and

3. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and

4. Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA

Abstract

Key Points In patients with Ph+ ALL, achievement of CMR at 3 months is independently associated with improved survival. CMR at 3 months may identify patients with Ph+ ALL who have excellent long-term outcomes without SCT in first CR.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/128/4/504/1397550/504.pdf

Reference16 articles.

1. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.;Brüggemann;Blood,2006

2. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.;Gökbuget;Blood,2012

3. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.;Ribera;J Clin Oncol,2014

4. Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia.;Ravandi;Br J Haematol,2016

5. Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.;Dhédin;Blood,2015

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of Measurable Residual Disease in Adult Philadelphia Chromosome–Positive ALL: A GRAAPH-2014 Study;Journal of Clinical Oncology;2024-09-10

2. SOHO State of the Art Updates and Next Questions | Novel Agents and the Diminishing Role of Allogeneic Stem Cell Transplant in B-Acute Lymphoblastic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia can be Treated with Chemotherapy-Free Regimens without Transplant;Clinical Lymphoma Myeloma and Leukemia;2024-09

4. Transplant in Adult ALL: Who and When;Clinical Lymphoma Myeloma and Leukemia;2024-09

5. Predicting relapse in acute lymphoblastic leukemia;Leukemia & Lymphoma;2024-08-31